These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26554)

  • 1. Elimination of radioactivity following administration of [15,16-3H]naltrexone to rats and guinea pigs.
    Ludden TM; Bathala MS; Malspeis L; Drum MA; Reuning RH
    Drug Metab Dispos; 1978; 6(3):321-8. PubMed ID: 26554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol.
    Malspeis L; Bathala MS; Ludden TM; Bhat HB; Frank SG; Sokoloski TD; Morrison BE; Reuning RH
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):43-65. PubMed ID: 810832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and disposition of naltrexone in man after oral and intravenous administration.
    Wall ME; Brine DR; Perez-Reyes M
    Drug Metab Dispos; 1981; 9(4):369-75. PubMed ID: 6114837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic reduction of naltrexone II. In vitro studies using liver from guinea pig, monkey and rat.
    Malspeis L; Ludden TM; Bathala MS; Morrison BE; Feller DR; Reuning RH
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):393-406. PubMed ID: 822483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of naltrexone in man.
    Wall ME; Brine DR; Perez-Reyes M
    NIDA Res Monogr; 1981; 28():105-31. PubMed ID: 6790999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone disposition in man after subcutaneous administration.
    Wall ME; Perez-Reyes M; Brine DR; Cook CE
    Drug Metab Dispos; 1984; 12(6):677-82. PubMed ID: 6150815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The urinary excretion profiles of naltrexone in man, monkey, rabbit, and rat.
    Dayton HE; Inturrisi CE
    Drug Metab Dispos; 1976; 4(5):474-8. PubMed ID: 10147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The stimulatory effect of morphine on reduction of naltrexone to 6 alpha-naltrexol in the guinea pig.
    Roerig SC; Fujimoto JM; Wang RI
    Drug Metab Dispos; 1980; 8(5):295-9. PubMed ID: 6107224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing of drug delivery systems for use in the treatment of narcotic addiction.
    Reuning RH; Malspeis L; Frank S; Notari RE
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):43-5. PubMed ID: 827709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition and pharmacokinetics of naltrexone after intravenous and oral administration in rhesus monkeys.
    Reuning RH; Ashcraft SB; Wiley JN; Morrison BE
    Drug Metab Dispos; 1989; 17(6):583-9. PubMed ID: 2575491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the oral, intravenous, and subcutaneous administration of 3H-naltrexone to normal male volunteers.
    Perez-Reyes M; Wall ME
    NIDA Res Monogr; 1981; 28():93-101. PubMed ID: 6791016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone metabolism and sustained release following administration of an insoluble complex to rhesus monkeys and guinea-pigs.
    Macgregor TR; Drum MA; Harrigan SE; Wiley JN; Reuning RH
    J Pharm Pharmacol; 1983 Jan; 35(1):38-42. PubMed ID: 6131962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration.
    Meyer MC; Straughn AB; Lo MW; Schary WL; Whitney CC
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):15-9. PubMed ID: 6469932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical pharmacology of naltrexone: pharmacology and pharmacodynamics.
    Verebey K
    NIDA Res Monogr; 1981; 28():147-58. PubMed ID: 6791001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The identification and measurement of two new metabolites of naltrexone in human urine.
    Cone EJ; Gorodetzky CW; Darwin WD; Carroll FI; Brine GA; Welch CD
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):413-33. PubMed ID: 674824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The seminal excretion, plasma elimination, tissue distribution and metabolism of naltrexone in the rabbit.
    Taylor SM; Rodgers RM; Lynn RK; Gerber N
    J Pharmacol Exp Ther; 1980 May; 213(2):289-99. PubMed ID: 7365688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative determination of naltrexone, 6 beta-naltrexol and 2-hydroxy-3-methoxy-6 beta-naltrexol (HMN) in human plasma, red blood cells, saliva and urine by gas liquid chromatography.
    Verebey K
    NIDA Res Monogr; 1981; 28():36-51. PubMed ID: 6791012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gas-liquid chromatographic method for the determination of naltrexone and beta-naltrexol in human urine.
    Verebely K; Mulé SJ; Jukofsky D
    J Chromatogr; 1975 Aug; 111(1):141-8. PubMed ID: 239958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro potency studies of 6beta-naltrexol, the major human metabolite of naltrexone.
    Porter SJ; Somogyi AA; White JM
    Addict Biol; 2002 Apr; 7(2):219-25. PubMed ID: 12006217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.
    Dunbar JL; Turncliff RZ; Dong Q; Silverman BL; Ehrich EW; Lasseter KC
    Alcohol Clin Exp Res; 2006 Mar; 30(3):480-90. PubMed ID: 16499489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.